LeMaitre Vascular, Inc. (LMAT) Social Stream



LeMaitre Vascular, Inc. (LMAT): $78.75

0.64 (-0.81%)

POWR Rating

Component Grades

Momentum

F

Stability

C

Sentiment

Quality

B

LEMAITRE VASCULAR INC (LMAT) Price Targets From Analysts

Use the tables below to see what analysts covering LEMAITRE VASCULAR INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 5 $70 $58 $62.5 $55.19 13.25%
2022-01-06 5 $70.001 $58 $62.5 $55.19 13.25%
2022-01-21 4 $70.001 $48 $59.5 $55.19 7.81%
2022-02-24 5 $65 $48 $58.25 $55.19 5.54%
2022-02-25 5 $65 $48 $56.25 $55.19 1.92%
2022-04-28 5 $65 $48 $53.75 $55.19 -2.61%
2022-05-01 5 $65 $48 $52.75 $55.19 -4.42%
2022-07-29 5 $65 $45 $52 $55.19 -5.78%
2022-08-03 5 $65 $48 $53.25 $55.19 -3.52%
2022-09-15 5 $65 $48 $54 $55.19 -2.16%
2022-10-12 5 $56 $48 $51.75 $55.19 -6.23%
2022-10-27 5 $56 $48 $51.75 $55.19 -6.23%
2022-11-07 4 $56 $46 $50.75 $55.19 -8.04%
2023-02-23 5 $57 $46 $51 $55.19 -7.59%
2023-03-07 5 $57 $48 $51 $55.19 -7.59%
2023-05-03 5 $63 $48 $53 $55.19 -3.97%
2023-08-01 5 $63 $54 $59.75 $55.19 8.26%
2023-08-03 6 $75 $54 $64.4 $55.19 16.69%
2023-08-09 6 $75 $58 $65.2 $55.19 18.14%
2023-09-06 7 $75 $58 $66 $55.19 19.59%
2023-09-21 6 $75 $58 $66 $55.19 19.59%
2023-10-23 7 $75 $58 $65.142 $55.19 18.03%
2023-11-02 7 $75 $50 $61.142 $55.19 10.78%

The Trend in the Analyst Price Target


LMAT's average price target has moved down $2.27 over the prior 27 months.

Over the past 36 weeks, LMAT's average upside potential has been 12.82%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-23 5 57 46 50.333 49.18 2.34%
2023-05-03 5 63 48 53.000 63.09 -15.99%
2023-08-01 5 63 54 59.750 62.82 -4.89%
2023-09-06 7 75 58 66.000 56.65 16.5%
2023-11-02 6 75 50 61.142 46.65 31.07%

LMAT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.67 4 0 2 0 0 6

The Trend in the Broker Recommendations


Over the past 16 months, LMAT's average broker recommendation rating improved by 0.53.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how LEMAITRE VASCULAR INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 2618.07% of that group.
  • LEMAITRE VASCULAR INC's upside potential (average analyst target price relative to current price) is higher than 464.32% of stocks in the small market cap category.
  • In the context of Healthcare stocks, LEMAITRE VASCULAR INC's variance in analysts' estimates is lower than -448.56% of them.
  • In the context of Healthcare stocks, LEMAITRE VASCULAR INC's number of analysts covering the stock is greater than 791.87% of them.

Stocks similar to LEMAITRE VASCULAR INC in the Medical Equipment industry regarding analyst recommendations and price targets are CERS, RVP, and SRDX.

Is LMAT a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!